TDOC vs AMWL Stock Comparison: AI Score, Valuation, Performance and Upside
Teladoc and American Well both operate in the telehealth industry navigating a post-pandemic demand reset, but Teladoc operates a more direct virtual care service model spanning general medical, mental health, and chronic care, while American Well operates a platform model enabling health systems and payers to deliver their own branded telehealth services.
Teladoc offers exposure to a diversified, direct virtual care service provider with scale advantages, while American Well offers exposure to a platform-based model serving health systems and payers directly. Consider whether you prefer Teladoc's diversified direct care model or American Well's enabling technology platform approach.
TDOC holds the edge across 3 of 5 key metrics in this comparison. AMWL leads on both 1-year return (+147.18%) and forward P/E quality (-8.06x vs -8.23x for TDOC), a relatively favorable combination of momentum and valuation. TDOC leads on both revenue growth (-4.00%) and operating margin (-5.68%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for TDOC (+18.68%) than for AMWL (+0.55%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want exposure to a diversified virtual care provider spanning general medical, mental health, and chronic care services
- Believe scale advantages support broader service coverage and provider network depth
- Are comfortable with growth rates that have moderated substantially from pandemic-era peaks
- Value established relationships with health plans and employers as a distribution channel
- Prefer a platform-based telehealth model that enables health systems and payers to deliver their own branded services
- Believe continued platform adoption by large healthcare organizations will drive future growth
- Are comfortable with the execution risk inherent in a still-developing path to sustained profitability
- Value a more capital-efficient enabling technology approach over direct care delivery
| Metric | TDOC | AMWL |
|---|---|---|
| AI scorei | 25.2 | 23.5 |
| AI ranki | #2968 | #3500 |
| Latest closei | $8.51 | $12.73 |
| 1M returni | +46.72% | -6.26% |
| 3M returni | +26.83% | +18.42% |
| 6M returni | +31.73% | +108.01% |
| 1Y returni | -2.63% | +147.18% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | TDOC | AMWL |
|---|---|---|
| 1Y ago | $9.74K (-2.6%) started 2025-10-30 | $24.72K (+147.2%) started 2025-10-30 |
| 5Y ago | $561.6 (-94.4%) started 2021-11-01 | $669.3 (-93.3%) started 2021-11-01 |
| 10Y ago | $5.24K (-47.6%) started 2016-10-31 | $275.9 (-97.2%) started 2020-09-17 |
Hypothetical — past performance does not guarantee future results.
| Metric | TDOC | AMWL |
|---|---|---|
| Market capi | $1.17B | $216.52M |
| Trailing P/Ei | N/A | N/A |
| Forward P/Ei | -8.23 | -8.06 |
| Price/Salesi | N/A | 0.99 |
| EV/Revenuei | 0.56 | 0.17 |
| Analyst targeti | $7.67 | $12.80 |
| Target upsidei | +18.68% | +0.55% |
| Metric | TDOC | AMWL |
|---|---|---|
| Revenue growthi | -4.00% | -26.60% |
| Earnings growthi | N/A | N/A |
| EPS growthi | N/A | N/A |
| FCF margini | +7.67% | +1.77% |
| Operating margini | -5.68% | -19.59% |
| Profit margini | -7.13% | -35.75% |
| ROIC proxyi | -12.98% | -29.12% |
| Return on equityi | -12.98% | -29.12% |
| Dividend yieldi | N/A | 0.00% |
| Payout ratioi | N/A | 0.00% |
| Dividend growth streaki | N/A | N/A |
| Betai | 2.13 | 1.68 |
| Debt/equityi | 79.09 | 1.27 |
| Current ratioi | 0.83 | 2.90 |
| Quick ratioi | 0.73 | 2.72 |
Over the past year, TDOC and AMWL have moved weakly in the same direction (correlation of 0.38), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | TDOC | AMWL |
|---|---|---|---|
| 1Y | Growthi | -2.63% | +147.18% |
| CAGRi | -2.63% | +147.34% | |
| Volatilityi | 65.40% | 73.37% | |
| Sharpe ratioi | 0.22 | 1.53 | |
| Sortino ratioi | 0.33 | 2.79 | |
| Max drawdowni | 48.86% | 27.59% | |
| Current drawdowni | 12.45% | 15.02% | |
| Avg drawdowni | 26.42% | 9.02% | |
| Ulcer Indexi | 29.45% | 11.34% | |
| Max daily dropi | 28.32% | 15.02% | |
| Max wkly dropi | 28.31% | 22.77% | |
| 5Y | Growthi | -94.38% | -93.31% |
| CAGRi | -43.82% | -41.81% | |
| Volatilityi | 66.82% | 78.87% | |
| Sharpe ratioi | -0.59 | -0.36 | |
| Sortino ratioi | -0.82 | -0.56 | |
| Max drawdowni | 97.10% | 98.02% | |
| Current drawdowni | 94.48% | 93.34% | |
| Avg drawdowni | 85.47% | 81.99% | |
| Ulcer Indexi | 86.85% | 84.12% | |
| Max daily dropi | 40.15% | 23.08% | |
| Max wkly dropi | 43.25% | 38.27% | |
| 10Y | Growthi | -47.63% | -97.24% |
| CAGRi | -6.27% | -44.40% | |
| Volatilityi | 61.42% | 78.36% | |
| Sharpe ratioi | 0.13 | -0.42 | |
| Sortino ratioi | 0.19 | -0.64 | |
| Max drawdowni | 98.48% | 99.56% | |
| Current drawdowni | 97.11% | 98.51% | |
| Avg drawdowni | 54.70% | 87.63% | |
| Ulcer Indexi | 67.60% | 90.10% | |
| Max daily dropi | 40.15% | 23.08% | |
| Max wkly dropi | 43.25% | 38.27% |
| Category | TDOC | AMWL |
|---|---|---|
| Company | Teladoc Health, Inc. | American Well Corporation |
| Sector | Healthcare | Healthcare IT |
| Industry | Health Information Services | Health Information Services |
| Core business | A virtual care company providing telehealth services including general medical consultations, mental health support, and chronic condition management through a technology platform serving individual, employer, and health plan customers. | A telehealth technology company providing a virtual care platform that enables health systems, health plans, and other healthcare organizations to deliver their own branded telehealth services to patients. |
| Investor focus | Mental health and chronic care segment growth, membership and utilization trends, and progress toward sustained profitability following the post-pandemic demand normalization. | Platform adoption by health system and health plan customers, revenue growth trajectory, and progress toward improved cash flow and profitability. |
- Diversified service offering spans general medical, mental health, and chronic condition management virtual care
- Established relationships with health plans and employers provide a distribution channel for telehealth services
- Scale as one of the largest telehealth providers supports broader service coverage and provider network depth
- Platform-based business model enables healthcare organizations to deliver telehealth under their own brand, differentiating from direct-to-consumer competitors
- Partnerships with large health systems and payers provide access to established patient populations
- Focus on enabling technology rather than direct care delivery allows for a more capital-efficient scaling approach
- Growth rates have moderated substantially from pandemic-era peaks, requiring new demand drivers to reaccelerate
- Path to consistent profitability has required ongoing cost discipline and business model adjustments
- Competitive telehealth landscape includes both dedicated virtual care companies and traditional healthcare providers building their own offerings
- Revenue growth has faced pressure as post-pandemic telehealth demand normalized from earlier elevated levels
- Profitability path requires continued platform adoption growth and disciplined cost management
- Smaller scale relative to larger telehealth competitors limits some negotiating leverage with large customers
Compare more than two at a time
This page is a fixed writeup on TDOC and AMWL. Our comparison engine is the interactive version: load up to five tickers, switch timeframes, and get the correlation, drawdown, and overlap analysis that a static page can't show.
Add three more names beside TDOC and AMWL, mixing stocks and ETFs in the same table — useful when the real question is which of a whole peer group to own.
AI score, forward P/E, analyst target upside, operating margin, and revenue growth are scored head-to-head, with a running tally of which ticker leads on how many metrics.
Volatility, Sharpe and Sortino ratios, maximum, current, and average drawdown, Ulcer Index, and worst single-day and single-week drops across every timeframe.
Pairwise daily-return correlation for every combination, so you can see whether two holdings actually diversify each other or just move together.
A scatter plot of forward P/E against return on equity, plus drawdown and 30-day rolling volatility charts, to separate what is cheap from what is merely beaten down.
For ETFs, a top-holdings comparison that exposes hidden overlap between funds. Every comparison exports to CSV for your own spreadsheet work.
Two comparisons a week are free without an account. A 14-day trial removes the limit and adds AI price forecasts, stock rankings, saved watchlists, and the intrinsic value calculator — no credit card required.
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.